Your browser doesn't support javascript.
loading
Design, synthesis, and structure-activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor ß (TRß) selective agonists.
Shiohara, Hiroaki; Nakamura, Tetsuya; Kikuchi, Norihiko; Ozawa, Tomonaga; Matsuzawa, Akane; Nagano, Ryuichi; Ohnota, Hideki; Miyamoto, Takahide; Ichikawa, Kazuo; Hashizume, Kiyoshi.
Afiliação
  • Shiohara H; Central Research Laboratory, Kissei Pharmaceutical Co., Ltd, 4365-1, Kashiwabara, Hotaka, Azumino-city, Nagano 399-8304, Japan. hiroaki_shiohara@pharm.kissei.co.jp
Bioorg Med Chem ; 21(3): 592-607, 2013 Feb 01.
Article em En | MEDLINE | ID: mdl-23276448
ABSTRACT
Highly TRß selective thyromimetics have several potential therapeutic applications. Based on the novel indane derivative KTA-439 with high receptor (TRß) and organ (liver) selectivity, a series of thyroid hormone analogues were prepared, in which the isopropyl at the 3'-position was replaced with alkyl and aralkyl moieties of variable lengths and branches. Binding assays for these human TRs and reporter cell assays showed that 2-arylethyl derivatives had higher TRß selectivity than KTA-439. KTA-574, a representative 2-arylethyl derivative, had TRß specificity in a binding assay and exhibited full agonism in a reporter cell assay.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Receptores beta dos Hormônios Tireóideos / Malonatos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Receptores beta dos Hormônios Tireóideos / Malonatos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Japão